The top five episodes of our podcast in the year 2024, highlighted.
Related Posts
High-Dose Ocrevus Falls Short of Primary Endpoint in Relapsing Multiple Sclerosis Trial
Credit: ralwel | stock.adobe.com Roche has announced results from the Phase III MUSETTE clinical trial of high-dose Ocrevus (ocrelizumab) intravenous…
The Role of Human Oversight With Artificial Intelligence in Clinical Research
ACT: How important is it that a level of human intervention remains with the oversight of these artificial intelligence (AI)…
Prioritizing Data Quality Amidst Complexity in Clinical Trials
In a recent video interview with Applied Clinical Trials, Silvio Galea, chief data & analytics officer, WCG, discussed the challenges in…